US to release monkey pox vaccine from national stockpile for 'high-risk' people
Advertisement
The United States is responding to a request for the release of monkeypox vaccine from the nation's Strategic National Stockpile as a global outbreak of cases is under investigation.
There is one confirmed case of monkeypox and four suspected cases in the United States, the US Centers for Disease Control and Prevention as of 23rd may. In the United States, the two-dose Jynneos vaccine is licensed to prevent smallpox and specifically to prevent monkeypox.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.